Document in PDF format

Get Adobe® Reader®

Products

Our portfolio of services and pharmaceutical products in Canada include:

Products

ABRAXANE® (paclitaxel powder for injectable suspension; nanoparticle, albumin-bound (nab) paclitaxel)
 
ISTODAX® (romidepsin for injection)
 
OTEZLA® (apremilast tablets)
 
POMALYST® (pomalidomide capsules)
 
REVLIMID® (lenalidomide capsules)
 
THALOMID® (thalidomide capsules)
 
VIDAZA® (azacitidine for injection)
 
ABRAXANE®, ISTODAX®, OTEZLA®, POMALYST®, REVLIMID®, THALOMID®, VIDAZA® are registered trademarks of Celgene Corporation.
 
These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the Canada, please contact the local office (as listed in Locations under About Us).